|
1
|
A population pharmacokinetic/pharmacodynamic analysis of regadenoson, an adenosine A2A-receptor agonist, in healthy male volunteers.
|
Clin Pharmacokinet
|
2006
|
1.24
|
|
2
|
Ranolazine, a partial fatty acid oxidation (pFOX) inhibitor, improves left ventricular function in dogs with chronic heart failure.
|
J Card Fail
|
2002
|
1.16
|
|
3
|
Short-term treatment with ranolazine improves mechanical efficiency in dogs with chronic heart failure.
|
Circ Res
|
2002
|
1.12
|
|
4
|
Primary and delayed closure after open irrigation and debridement of septic arthritis in children.
|
J Pediatr Orthop B
|
2005
|
0.75
|